Denise Wolko is an experienced professional in the pharmaceutical industry, currently serving as Executive Director and Head of Medical Writing and Transparency at Jazz Pharmaceuticals since September 2018. Prior roles at Jazz Pharmaceuticals include Senior Director of Biometrics & Medical Writing and Director of Medical Writing and Transparency. Denise's earlier experience includes serving as Director of Medical Writing Oncology at Merck from May 2017 to September 2018, and as Global Principal Clinical Scientist at CSL Behring from May 2014 to May 2017. Denise's extensive career at Merck began in May 1996, progressing from Research Chemist to Senior Clinical Research Scientist. Denise holds a Master of Arts in Physical Chemistry from Temple University.